查詢結果分析
來源資料
相關文獻
- 肥胖是否為傳染病
- The Effectiveness of Dietary Instruction in Obese School Children of Southern Taiwan
- 肥胖婦女減重前後體組成及熱量代謝之變化
- 青少年肥胖問題之探討
- Surgical Treatment of Morbid Obesity with Vertical Banded Gastroplasty: A Comparison between TA90-4.8 and TA90-B
- 肥胖兒童的脂質代謝
- 臺中市學童肥胖盛行率之分析:不同篩選指標的比較
- 肥胖婦女減重對其與常見代謝疾病相關之血中指標之影響
- 臺中市學齡兒童肥胖症與父母親體型相關性之研究
- 二週運動減肥對男性肥胖基因表現物Leptin之影響
頁籤選單縮合
題 名 | 讓你酷--簡介=Xenical |
---|---|
作 者 | 曾今坤; 陳永煌; 田健堯; 周稚傑; | 書刊名 | 中華職業醫學雜誌 |
卷 期 | 6:4 1999.10[民88.10] |
頁 次 | 頁291-296 |
分類號 | 415.599 |
關鍵詞 | 肥胖; |
語 文 | 中文(Chinese) |
中文摘要 | 肥胖在未來將會是最嚴重醫療問題之一。勞工朋友中有體重過重困擾的不在少數 ,肥胖和高血壓、糖尿病、高血脂、骨質疏鬆等重大疾病都有密不可分之關連性。很多勞工 朋友會自行購買減肥藥服用。而幾年前很多愛美女士購買減肥藥,造成多例因肺部纖維死亡 之案例。很多減肥藥物結構類似甲狀腺素及安排他命,有些以輕溶劑混充,造成很多副作用 ,希望勞工朋友服用任何藥物,一定要經過醫師處方。當然近日讓你酷受到各界矚目,本文 回顧相關資訊,提供各位醫師做參考。未來此藥若引進臺灣,可做為依循,當然減肥首要之 原則「少吃多動」,如果僅靠藥物,絕不可能達成目的。 |
英文摘要 | Administration is orlistat (Xenical), a pancreatic lipase inhibitor that reduces the absorption of dietary fat by approximately 30%, thus reducing energy intake. In a 1-year placebo-controlled trial, 55% of patients receiving orlistat lost more than 5% of their body weight, and 25% lost more than 10% of their body weight, compared with 33% and 15%, respectively, of patients in the placebo group. In addition, orlistat slowed the rate of weight regain in the second year of treatment. Health benefits demonstrated in clinical trials of orlistat include reduced LDL cholesterol levels and increased levels of HDL cholesterol, reduced blood pressure and fasting insulin levels, improved oral glucose tolerance test outcomes, and improved glycemic control in obese patients with diabetes. The future of the pharmacologic treatment of obesity is promising. Many new antiobesity agents are in the early stages of development, and our understanding of the body's weight-regulating mechanisms is advancing steadily. Human trials of recombinant leptin are underway. Other promising compounds include those that block the Neuropeptide Y5 and Y1 (NY5, NY1) and Melanocortin-4 (MC4) receptors, stimulate uncoupling proteins, and unbind corticotrophin-releasing factor from its binding protein. As better medical treatments for obesity become available, the focus in dietary prescription may shift away from reducing energy intake toward healthier eating for disease prevention. At present, a comprehensive approach, which, in some patients, may include medical therapy as an adjunct, is necessary to treat obesity effectively. |
本系統中英文摘要資訊取自各篇刊載內容。